期刊文献+

结核病诊治进展与科技革命 被引量:2

Progress of Diagnosis and Treatment in Mycobacterial Tuberculosis and Science and Technology Revolution
下载PDF
导出
摘要 现代科技革命极大地促进了结核病各方面的发展。微生物学和免疫学的发展 ,揭示了结核病的病因、发病机制、病理生理的本质 ,分子生物学技术使结核病的基础研究不仅停留在器官、细胞水平 ,而是深入到蛋白质、核酸、基因的水平 ;基因治疗的方法可望从根本上治疗结核病。高新技术的产物如X线照片、电子计算机断层扫描、纤维支气管镜检查和新药的出现等极大地提高了临床诊治的能力。借助于各种先进的医疗设备而进行精确的诊断 ,基因治疗将成为一种崭新的治疗手段。 Modern science and technology revolution exerts progress of diagnosis a nd treatment of mycobacterial tuberculosis.The development of microbiology and i mmunology have been revealing the nature of cause,pathogenic mechanism,physiolog y and pathology of mycobacterial tuberculosis.The application of molecular biolo gy and the studies probe have not only the levels of organ and cell,but also the levels of protein,nucleic acid and gene.Gene therapy is expected to yield a rad ical cure of mycobacterial tuberculosis.The products of modern technology includ ing X-ray photo,computerized tomography,fibrous bronchoscopy and other technique s have greatly improved the capacity of diagnosis and treatment of mycobacterial tuberculosis.Diagnosis and treatment of mycobacterial tuberculosis is focused o n,besides the traditional drugs and surgical operations,precise diagnosis with t he help of various advanced medical equipment,as to the treatment,new therapeuti c methods such as gene therapy is also applied.
出处 《医学与哲学》 2004年第11期53-55,共3页 Medicine and Philosophy
关键词 结核病 基因治疗 诊断 X线照片 电子计算机断层扫描 治疗手段 纤维支气管镜检查 科技革命 发展 高新技术 modern science and technology mycobacterial tuberculosi s molecular biology diagnosis treatment
  • 相关文献

参考文献10

  • 1FLUITAC, VISSERMR,SCHMITZFJ. Molecular detection of antimicrobial resistance[J]. Clin Microbiol Rev,2001,14:846 - 871.
  • 2ALVARADO - ESQUIVEL C, ROSSAU R, MATINEA - GARCIA S,et al. Characterization of ropB gene mutation in rifampicin resistant Mycrobacterium tuberculosis strains isolated from pulmonary tuberculosis patients at Mexican public hospitals[J ]. Rev Invest Clin, 2
  • 3DROBNIEWSKI F A, WILSON S M. The rapid diagnosis of isoniazid and rifampicin resistance in Mycrobacterium tuberculosis- a molecular story[J]. J Med Microbio, 1998,47:189-196.
  • 4MOKROUSOV I, OTTEN T, VYSHNESKIY B, et al. Detection of embB 306 mutations in emthambutol - susceptible clinical isolates of Mycobacterium tuberculosis from North West Russia: implications for genotypic resistant testing[J]. J Clin Microbiol, 2002, 40:3 8
  • 5TELENTI A, HONORE N,BERNASCONI C, et al. Genotypic assessment of isoniazid and rifampicin resistance in mycobacterium tuberculosis: a blind at reference laboratory level[J ]. J Clin Microbiol,1997,35: 719 - 723.
  • 6RAMASWAMYSV, AMINAG, GOKSELS,etal. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis[J ]. Antimicrob Agents Chemother,2000,44: 326 - 36.
  • 7RAMASWAMY S V, REICH R, DOU S J, et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in mycobacterium tuberculosis[J ]. Antimicrob Agents Chemother,2003,47:1 241- 1 250.
  • 8RAMASWAMYSV, DOUSJ, RENDONA, et al. In Vitro Inhibition of the Mycobacterium tuberculosis {beta} - Ketoacyl- Acyl Carrier Protein Reductase MabA by Isoniazid[J ]. J Clin Microbiol, 2004,42:2 425- 2 431.
  • 9李经纬 程之范.中国医学百科全书.医学史[M].上海:上海科学技术出版杜,1987.241-242、243、390-391.
  • 10王鸿.结核病领域基础研究的现状与高技术前景[J].广州医药,1993,24(1):4-6. 被引量:2

共引文献1

同被引文献7

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部